Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

• Main Authors: Schwartz, GG, Szarek, M, Bittner, VA, Diaz, R, Goodman, SG, Jukema, JW, Landmesser, U, López-Jaramillo, P, Manvelian, G, Pordy, R, Scemama, M, Sinnaeve, PR, White, HD, Gabriel Steg, P, Gabriel Steg, PH, Bhatt, DL, Harrington, RA, Zeiher, AM, Tricoci, P, Roe, MT, Mahaffey, KW, Edelberg, JM, Hanotin, C, Lecorps, G, Moryusef, A, Sasiela, WJ, Tamby, JF, Aylward, PE, Drexel, H, Sinnaeve, P, Dilic, M, Lopes, RD, Gotcheva, NN, Prieto, JC, Yong, H, Pećin, I, Reiner, Z, Ostadal, P, Poulsen, SH, Viigimaa, M, Nieminen, MS, Danchin, N, Chumburidze, V, Marx, N, Liberopoulos, E, Montenegro Valdovinos, PC, Tse, HF, Kiss, RG, Xavier, D, Zahger, D, Valgimigli, M, Kimura, T, Kim, HS, Kim, SH, Erglis, A, Laucevicius, A, Kedev, S, Yusoff, K, Ramos López, GA, Alings, M, Halvorsen, S, Correa Flores, RM, Sy, RG, Budaj, A, Morais, J, Dorobantu, M, Karpov, Y, Ristic, AD, Chua, T, Murin, J, Fras, Z, Dalby, AJ, Tuñón, J, Asita de Silva, H, Hagström, E, Müller, C, Chiang, CE, Sritara, P, Guneri, S, Parkhomenko, A, Ray, KK, Moriarty, PM, Vogel, R, Chaitman, B, Kelsey, SF, Olsson, AG, Rouleau, JL, Simoons, ML, Alexander, K, Meloni, C, Rosenson, R, Sijbrands, EJG, Alexander, JH, Armaganijan, L, Bagai, A, Bahit, MC, Brennan, JM, Clifton, S, DeVore, AD, Deloatch, S
• Other Authors: MEDICINE
• Format: Article
• Published: Elsevier BV 2022
• Subjects: PCSK9 inhibitor; acute coronary syndrome; lipoprotein(a); low-density lipoprotein cholesterol; Acute Coronary Syndrome; Aged; Antibodies, Monoclonal, Humanized; Cardiovascular Diseases; Cholesterol, LDL; Female; Humans; Lipoprotein(a); Male; Middle Aged; PCSK9 Inhibitors
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/228830
• Institution: National University of Singapore

10.1016/j.jacc.2021.04.102